| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Journal of Korean Neurosurgical Society 2009;45(5): 275-283.
doi: https://doi.org/10.3340/jkns.2009.45.5.275
Radiosurgery for Recurrent Brain Metastases after Whole-Brain Radiotherapy : Factors Affecting Radiation-Induced Neurological Dysfunction.
Ho Shin Gwak, Hyung Jun Yoo, Sang Min Youn, Dong Han Lee, Mi Sook Kim, Chang Hun Rhee
1Neuro-Oncology Clinic, National Cancer Center, Goyang, Korea.
2Department of Neurosurgery, Korea Institute of Radiological and Medical Science, Seoul, Korea. changhun@kcch.re.kr
3Department of Radiation Oncology, Korea Institute of Radiological and Medical Science, Seoul, Korea.
4Cyberknife Center, Korea Institute of Radiological and Medical Science, Seoul, Korea.
ABSTRACT
OBJECTIVE
We retrospectively analyzed survival, local control rate, and incidence of radiation toxicities after radiosurgery for recurrent metastatic brain lesions whose initial metastases were treated with whole-brain radiotherapy. Various radiotherapeutical indices were examined to suggest predictors of radiation-related neurological dysfunction.
METHODS
In 46 patients, total 100 of recurrent metastases (mean 2.2, ranged 1-10) were treated by CyberKnife radiosurgery at average dose of 23.1 Gy in 1 to 3 fractions. The median prior radiation dose was 32.7 Gy, the median time since radiation was 5.0 months, and the mean tumor volume was 12.4 cm3. Side effects were expressed in terms of radiation therapy oncology group (RTOG) neurotoxicity criteria.
RESULTS
Mass reduction was observed in 30 patients (65%) on MRI. After the salvage treatment, one-year progression-free survival rate was 57% and median survival was 10 months. Age (<60 years) and tumor volume affected survival rate (p=0.03, each). Acute (< or =1 month) toxicity was observed in 22% of patients, subacute and chronic (>6 months) toxicity occurred in 21%, respectively. Less acute toxicity was observed with small tumors (<10 cm3, p=0.03), and less chronic toxicity occurred at lower cumulative doses (<100 Gy, p=0.004). "Radiation toxicity factor" (cumulative dose times tumor volume of <1,000 Gyxcm3) was a significant predictor of both acute and chronic CNS toxicities.
CONCLUSION
Salvage CyberKnife radiosurgery is effective for recurrent brain metastases in previously irradiated patients, but careful evaluation is advised in patients with large tumors and high cumulative radiation doses to avoid toxicity.
Key Words: Brain; Metastasis; Radiotherapy; Toxicity; Radiosurgery; Recurrence
TOOLS
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Share:      
METRICS
9
Crossref
8
Scopus
2,674
View
32
Download
Related article
Stereotatic Radiosurgery for Brain Metastases: Prognostic Factors for Survival and Local Control.  2003 April;33(4)
Editorial Office
1F, 18, Heolleung-ro 569-gil, Gangnam-gu, Seoul, Republic of Korea
TEL: +82-2-525-7552   FAX: +82-2-525-7554   E-mail: kns61@neurosurgery.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Neurosurgical Society.                 Developed in M2PI
Close layer